Nvidias Blockbuster Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Shift Nuclear Energy Sector Attracts LongTerm Investor Interest Amid Global Clean Energy Transition Imagine Partners with Bojangles to Redefine InRestaurant Brand Experience Nationwide Shell SHEL Upgraded to Buy Following Transaction with ARC Resources Broadcom Meta Tech Giants Launch 125 Million Semiconductor Research Hub at UCLA Taiwan Chip Stocks Surge on Nvidias 150B Spending Plans Chinas Cambricon Slips UNP Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance RYDE Q2 2025 Earnings EPS Misses Estimates Shares Surge 947 Northfield Bancorp Inc NFBK Q1 2026 Earnings EPS Beat Sends Shares Slightly Lower Amid Cautious Outlook CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158 MITP Q1 2026 Earnings EPS Beats Estimates Amid Steady Mortgage Operations DDL Q4 2025 Earnings Profitability Milestone Despite Mixed Market Signals Nuwellis Inc NUWE Pushes Past Key Support Tests Resistance at 110 Exagen Inc XGN Inches Lower as Shares Test Key Support Near 405 BioMarin Pharmaceutical BMRN Edges Higher as Biotech Sector Shows Resilience Veritone VERI Edges Higher as Stock Consolidates Near Key Support LMP Capital and Income Fund SCD Narrows Slightly Holding Near Resistance Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Outlook OPTU Q1 2026 Earnings A Staggering EPS Miss Rattles Investors Northpointe Bancshares NPB Nudges Higher Near Support as Consolidation Continues ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline Turkcell Q4 2025 Earnings EPS of 440 Reported Amid Stock Pullback Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady DDS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Retail Environment Sonida Senior Living Inc Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares ALAB Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn